Health & Biotechnology
BIODOL
START-UP I iLab – Neuropathic painDIAG2TEC – MYELODIAG
START-UP I Oncology – Therapeutic diagnostic toolEDOP
START-UP I Patient Support – VideoAVIITAM
START-UP | TelemedecineNEURINNOV
START-UP I iLab – FT Seed – Nerve electrostimulationIMIQUALINES
AVAILABLE TECHNOLOGY | cancer – imiqualinesTCPase Inhibitors
START-UP I Thérapeutic moleculesRESIST-430
AVAILABLE TECHNOLOGY | Bacterial resistance to antibiotics – Gram-negative bacteria – Gamma-peptidesDIVINS
START-UP I AneurysmsAGV DISCOVERY
START-UP I Therapies oncology – Drug designPERSPECTYV
AVAILABLE TECHNOLOGY | Facioscapulohumeral dystrophy – Personalized treatment –SPOT-TO-LAB
START-UP I Diagnosis- BloodANATOSCOPE
START-UP I iLab – Customization anatomical modelTESOVIR
AVAILABLE TECHNOLOGY | HIV Reservoir – Biomarkers – mAbTARMAK
AVAILABLE TECHNOLOGY | Therapeutic combination – Synergy effect in pharmacology – Prostate cancerNATURAL PAD
START-UP I i Lab – Serious game – MedicinePL-VAC
AVAILABLE TECHNOLOGY | Leishmanioses – Secretomes – Multi-epitope peptide vaccineNOVAGRAY
START-UP I i Lab – Cancer Treatment – Radiation TherapyTELE-MOUV
MARKETED TECHNOLOGY I Chronic diseases – TelemedicineDEVINNOVA
START- UP I Patch – Infarction DetectionCILCARE
START-UP I Hearing – PharmacologyP42
AVAILABLE TECHNOLOGY I Peptide – HuntingtonSMICES
START-UP I FT Seed – SurgeryLipoSTAR
AVAILABLE TECHNOLOGY | Lipophenols – Carbonyl and oxidative stresses – MMP-9SPIMA
AVAILABLE TECHNOLOGY | Stapled Peptides – Inflammatory diseases – OncologyVACCIN MALADIE DE NEWCASTLE
AVAILABLE TECHNOLOGY I Vaccine – FarmsNANOMEDSYN
START-UP I i Lab – Lysosomal DiseaseCAPDCM
AVAILABLE TECHNOLOGY | Microfluidics – Chemoattraction – Drug releaseOMUNIS
START-UP I i Lab – Tuberculosis ScreeningEPIDROP
AVAILABLE TECHNOLOGY I Circulating tumor cellsTIX001
AVAILABLE TECHNOLOGY | Prevention of the toxicity of DNA-damaging anti-cancer agents – Chemotherapy and radiotherapy – Improvement of anti-cancer treatment efficacyNANO4SCHIZO
AVAILABLE TECHNOLOGY | Nanobody – Schizophrenia – mGlu2DIADX
START-UP I Oncology – Circulating DNA AnalysisALPHA-CENTAURI
AVAILABLE TECHNOLOGY | Innate immunity – Infectious diseases – Cancer3D-CELLS
AVAILABLE TECHNOLOGY | Sub-micron fiber matrix – Electrospinning – 3D cell culturePARADEV
START-UP I Diagnosis – ParasitosisEKILIA
START-UP I Telemedicine SoftwareAZELEAD
START-UP I i Lab – Test toxicityRESIST-655
AVAILABLE TECHNOLOGY | Bacterial resistance to antibiotics – Gram-negative bacteria – Heterocyclic compoundsEMOSIS
START-UP I i Lab – Diagnostic Kit – HemostasisLRAs
AVAILABLE TECHNOLOGY | HIV – Shock & Kill Strategy – LRAsMSC 2.0
AVAILABLE TECHNOLOGY | Myocardial infarction – Human mesenchymal stem cells – Innovative cell therapyDOCK 5
AVAILABLE TECHNOLOGY | Osteolytic diseases – Dock5 – NCEBIOSCIENCIA
START-UP I Purification natural proteinsGeniaTer-CMT1A
MARKETED TECHNOLOGY | Gene therapy – Nontraumatic intraneural injection – CMT1ANODIA
AVAILABLE TECHNOLOGY I Diabete – Inhibitor